News
2d
Pharmaceutical Technology on MSNModerna’s updated Covid-19 vaccine gets Canadian approval
Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 ...
The outlook for COVID boosters has never been as uncertain with schools reopening, day cares filling up and respiratory virus ...
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA / ACCESS ...
Coronavirus infections are climbing again, marking another summer wave as children go back to school. But this uptick arrives ...
As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...
The approval keeps Moderna on track to deliver doses ahead of the 2025-2026 vaccination season. Production will take place in ...
The biotech company said Friday the latest version of its Covid-19 mRNA vaccine, Spikevax, has been authorized by Health Canada. And for the first time, all pre-filled syringe doses of the vaccine ...
The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...
14don MSN
Vaccinating young children against Covid-19 may be more challenging this respiratory virus season
Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...
Moderna also announced that it has initiated a submission to the FDA for emergency use authorization of the company's Covid-19 vaccine for children ages 6 through 11 years old.
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the ...
CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results